Emergent BioSolutions (EBS) Exchange Rate Effect (2010 - 2025)
Emergent BioSolutions' (EBS) quarterly Exchange Rate Effect came in at -$200000.0 in Q3 2025, down 120.0% quarter-over-quarter from $1.0 million in Q2 2025.
Emergent BioSolutions (EBS) Exchange Rate Effect (2010 - 2025) Analysis & Trends
Emergent BioSolutions' Exchange Rate Effect history runs 15 years deep, the most recent figure standing at -$200000.0 for Q3 2025.
- On a quarterly basis, Exchange Rate Effect changed N/A year-over-year to -$200000.0 in Q3 2025; TTM through Mar 2026 was $800000.0, a 214.29% increase from a year earlier, with the FY2025 full-year figure at $100000.0, changed N/A from the prior year.
- Exchange Rate Effect declined to -$200000.0 in Q3 2025 per EBS's latest filing, from $1.0 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2022 and bottomed at -$1.5 million in Q4 2023.
- The 4-year median for Exchange Rate Effect is -$200000.0 (2021), against an average of -$64285.7.
- Across the five-year window, Exchange Rate Effect tumbled 400.0% in 2021 and soared 250.0% in 2022, its largest moves.
- Year by year, Exchange Rate Effect stood at -$200000.0 in 2021, then surged by 650.0% to $1.1 million in 2022, then plunged by 236.36% to -$1.5 million in 2023, then jumped by 86.67% to -$200000.0 in 2025.
- Per Business Quant, the three latest EBS Exchange Rate Effect figures stand at -$200000.0 (Q3 2025), $1.0 million (Q2 2025), and -$700000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Emergent BioSolutions | 389.77 Mn | 228.27 Mn | 84.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -200,000.00 |
| Sep 30, 2025 | -200,000.00 |
| Jun 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | -700,000.00 |
| Mar 31, 2025 | -700,000.00 |
| Dec 31, 2023 | -1.50 Mn |
| Dec 31, 2023 | -1.50 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | -600,000.00 |
| Jun 30, 2023 | -600,000.00 |
| Mar 31, 2023 | -200,000.00 |
| Mar 31, 2023 | -200,000.00 |
| Dec 31, 2022 | 1.10 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | -1.00 Mn |
| Sep 30, 2022 | -1.00 Mn |
| Jun 30, 2022 | 700,000.00 |
| Jun 30, 2022 | 700,000.00 |